Treatment of hairy-cell leukemia with cladribine: Response, toxicity, and long-term follow-up

Journal of Clinical Oncology

Volumn 15, Issue 3, 1997, Pages 1138-1142

  Hoffman, M A ^a   Janson, D ^a   Rose, E ^a   Rai, K R ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLADRIBINE; INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG RESPONSE; FATIGUE; FEMALE; HAIRY CELL LEUKEMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

EID: 0031057250     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.3.1138     Document Type: Article

References (28)

1. Turner A, Kyeldsberg CR: Hairy cell leukemia: A review. Medicine 57:477-499, 1978
2. Jaiyesimi IA, Kantarjian HM, Estey H: Advances in therapy for hairy cell leukemia. A review. Cancer 72:5-16, 1993
3. Grever M, Kopecky K, Foucar MK, et al: Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: An intergroup study. J Clin Oncol 13:974-981, 1995
4. Carson DA, Wasson DB, Kaye J, et al: Deoxycytidine kinase mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine 1210 leukemia in vivo. Proc Natl Acad USA 77:6865-6869, 1980
5. Robertson LE, Plunkett W: Apoptotic cell death in chronic lymphocytic leukemia. Leuk Lymphoma 11:71-74, 1993 (suppl 2)
6. Seto S, Carrera J, Kubota M, et al: Biochemical basis of deoxycytidine and 2-chlorodeoxyadenosine toxicity to non dividing human lymphocytes. J Clin Invest 75:377-383, 1985
7. Piro LD, Carrera CJ, Carson DA, et al: Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. New Engl J Med 322:1117-1121, 1990
8. Saven A, Piro LD, Carrera CJ, et al: Hairy cell leukemia: New understanding of biology and treatment. Cancer Treat Res 64:15-34, 1993
9. Juliusson G, Lilliemark J: Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2-deoxyadenosine (2-CdA): Relation to opportunistic infections. Blood 79:888-894, 1992
10. Estey EH, Kurzrock R, Kantarjian HM, et al: Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). Blood 79:882-887, 1992
11. Tallman MS, Hakimian D, Variakojis D, et al: A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia. Blood 80:2203-2209, 1992
12. Lauria F, Benefenati D, Zinzani PL, et al: 2-chlorodeoxyadenosine in the treatment of hairy cell leukemia patients relapsed after alpha interferon. Blood 78:34a, 1991 (suppl 1; abstr)
13. Seymour JF, Kurzrock R, Freireich EJ, et al: 2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia. Blood 83:2906-2911, 1994
14. Anonymous: Consensus resolution: Proposed criteria for evaluation of response to treatment in hairy cell leukemia. Leukemia 1:405, 1987
15. Fischer DS, Knobf MT, Durivage MJ: The Cancer Chemotherapy Handbook. St Louis, MO, Mosby, 1993, pp 501-505
16. Mercieca J, Matutes E, Moskovic E, et al: Massive abdominal lymphadenopathy in hairy cell leukemia: A report of 12 cases. Br J Haematol 82:547-554, 1992
17. Saven A, Piro L: Treatment of hairy cell leukemia. Blood 79:1111-1120, 1992
18. Wheaton S, Tallman MS, Hakimian D, et al: Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine. Blood 87:1556-1560, 1996
19. Filleul B, Delannoy A, Ferrant A, et al: A single course of 2-chloro-deoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission. Leukemia 8:1153-1156, 1994
20. Hakimian D, Tallman MS, Kiley C, et al: Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia. Blood 82:1798-1802, 1993
21. Berman E, Heller G, Kempin S, et al: Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alfa-2a. Blood 75:839-845, 1990
22. Rai KR, Davey F, Peterson B, et al: Recombinant alpha-2b interferon in therapy of previously untreated hairy-cell leukemia: Long term follow-up results of study by Cancer and Leukemia Group B. Leukemia 9:1166-1120, 1995
23. Catovsky D, Matutes E, Talavera JG, et al: Long term results with 2′-deoxycoformycin in hairy cell leukemia. Leukemia Lymphoma 14:109-113, 1994 (Suppl 1)
24. Kraut EH, Grever ML, Bouronde BA, et al: Long term follow-up of patients with hairy cell leukemia after treatment with 2′-deoxycoformycin. Blood 84:4061-4063, 1994
25. Saven A, Piro L: Complete remissions in hairy cell leukemia with 2-chlorodeoxyadenosine after failure with 2′-deoxycoformycin. Ann Intern Med 119:278-283, 1993
26. Sainati L, Matutes E, Mulligan S, et al: A variant form of hairy cell leukemia resistant to α-interferon: Clinical and phenotypic characteristics of 17 patients. Blood 76:157-162, 1990
27. Seymour B, Estey EH, Keating MJ, et al: Response to interferon-α in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine. Leukemia 9:929-932, 1995
28. Carrera CJ, Piro LD, Saven A, et al: Restoration of lymphocyte subsets following 2-chlorodeoxyadenosine remission induction in hairy cell leukemia. Blood 76:260a, 1990 (suppl 1; abstr)